Evidence map›Paper›PMID 42149176›Full record

ReviewRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer2026

Computed Tomography and Magnetic Resonance Imaging.

Morgan McLaughlin, Marcel van Straten, Esther A H Warnert, Marjolein Verhoeven, Sandra T van Tiel, Jeroen Essers, Gustav J Strijkers, Bram F Coolen, Monique R Bernsen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Morgan McLaughlinDepartment of Biomedical Engineering and Physics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Marcel van StratenDepartment of Radiology, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.
Esther A H WarnertDepartment of Radiology, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.
Marjolein VerhoevenDepartment of Molecular Genetics, Department of Vascular Surgery, Department of Radiotherapy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Sandra T van TielAMIE Core Facility, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.
Jeroen EssersDepartment of Molecular Genetics, Department of Vascular Surgery, Department of Radiotherapy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Gustav J StrijkersDepartment of Molecular Genetics, Department of Vascular Surgery, Department of Radiotherapy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Bram F CoolenDepartment of Biomedical Engineering and Physics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Monique R BernsenAMIE Core Facility, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands. m.bernsen@erasmusmc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Imaging in Oncology is rapidly moving from the detection and size measurement of a lesion to the quantitative assessment of metabolic processes and cellular and molecular interactions. Increasing insights into cancer as a complex disease with involvement of the tumor stroma in tumor pathobiological processes have made it clear that for successful control of cancer, treatment strategies should not only be directed at the cancer cells but should also take aspects of the tumor microenvironment into account. This requires an understanding of the complex molecular and cellular interactions in cancer tissue. Recent developments in imaging technology have increased the possibility of imaging various pathobiological processes in cancer development and response to treatment. For computed tomography (CT) and magnetic resonance imaging (MRI), various improvements in hardware, software, and imaging probes have lifted these modalities from classical anatomical imaging techniques to techniques suitable for imaging and quantifying various physiological processes and molecular and cellular interactions. Next to a more general overview of possible imaging targets in oncology, this chapter provides an overview of the various developments in CT and MRI technology and some specific applications.

Indexed as

Magnetic Resonance ImagingNeoplasmsTomography, X-Ray ComputedAnimalsHumansTumor MicroenvironmentCTImaging biomarkersImaging probesImaging targetImaging technologyMRIMultimodality imagingParametric mappingTumor microenvironment

Identifiers

PMID42149176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.